index - Myasthenia Gravis: étiologie, physiopathologie & approches thérapeutiques

Dernières publications

Chiffres clés

58 Publications avec texte intégral

Open Access

47 %

Mots clés

Disease susceptibility Il-23 Experimental models Exercise Animal models Interferonopathy Autoimmunity Acetylcholine receptor Autoimmune diseases Immune response Experimental autoimmune myasthenia gravis B cells Complete Freund's adjuvant Thymic epithelial cells Cardiomyopathy Thymectomy Genetic associations Interleukine-23 Etiology Chronic inflammation Anticorps monoclonal Transcriptome Myasthenia Gravis BAFF Interferon Interferon de type I M3243AG AChR antibodies Antimir-150 Acetylcholine receptor antibodies Immunology and Microbiology Section Ferrites LMNA Genetics Experimental mouse models Immune regulation Age Fragile X syndromes Innate immunity Immunotherapy Interféron de type I Myasthénie grave Early-onset myasthenia gravis Heart failure Interferon IFN FMR1 Cytokines Myasthenia gravis Neuromuscular junction Cellules th17 Interferon type-I Gender MG patients Quality of life Chemokine CTCF Acides nucléiques endogènes Immunity Interferon-β Germinal center Inflammatory cytokines Chemokines Centres germinatifs ectopiques Human myoblasts Inflammation Chronicity Aldehyde dehydrogenase biological marker CD31 antigen CD34 antigen CD45 antigen CD56 antigen adipocyte animal experiment animal model animal tissue antigen expression article cell differentiation cell function cell isolation cell labeling cell population cell selection controlled study endomysium enrichment culture enzyme activity enzyme substrate flow cytometry human human cell human tissue immunofluorescence in vitro study in vivo study mouse muscle biopsy muscle contraction muscle injury nonhuman phenotype skeletal muscle stem cell transplantation Adipogenesis Aldehyde Dehydrogenase Cell Differentiation Cells Cultured Flow Cytometry Humans Immunohistochemistry Muscle Cells Muscle Development Muscle Skeletal Phenotype Myoblasts Endogenous nucleic acids Gd T cells CD31 COVID-19 DICER Experimental autoimmune myasthenia gravis EAMG Long-term follow-up Autoimmunity Inflammation Neuromuscular junction Germinal centers Th17 Muscle regeneration Myasthenia Gravis MG Conduction disease Interleukin 23 Assay comparison Acetylcholine receptors Autoimmune disease Interferon type I Glucocorticoids Follicular hyperplasia Th17 cells Thymus Lamin A/C nuclei CCL21 Thymoma Adaptive immunity Ectopic germinal centers Clinical cell transplantation COX2 Auto-immunité Cell-cell communication PBMC MND CXCL13-CXCR5 Germinal centers